Stock Quote

Millipore Corporation (MIL) (NYSE Arca)
As of  4:04pm EST
68.30USD
Price Change
+0.57
Percent Change
+0.84%
 
$68.30
4:04pm EST
+0.84%
$67.73
$67.97
311,632
$68.85
$67.97
$72.99
$43.42
0.65
401,366

Research Another Stock: Symbol Look-up
US RESEARCH SUMMARY-S&P 500 March 12 1644 GMT
Thursday, 12 Mar 2009 12:44pm EDT 
US RESEARCH SUMMARY-S&P 500 March 12 1644 GMT
Thursday, 12 Mar 2009 12:44pm EDT(RTRS) 
US RESEARCH SUMMARY-S&P 500 March 12 1445 GMT
Thursday, 12 Mar 2009 10:46am EDT(RTRS) 
US RESEARCH SUMMARY-S&P 500 March 12 1415 GMT
Thursday, 12 Mar 2009 10:17am EDT(RTRS) 
Millipore Corporation Q3 2009 Earnings Call Transcript
Thursday, 5 Nov 2009 11:12pm EST(Seeking Alpha) 
Pundits Are Wrong: Healthcare Reform Will Increase Profits
Thursday, 17 Sep 2009 03:32am EDT(Seeking Alpha) 
Ken Griffin's Citadel Fund: Options Eye Candy
Thursday, 10 Sep 2009 03:06am EDT(Seeking Alpha) 
Hedge Fund Blue Ridge Concentrates on Apple
Thursday, 3 Sep 2009 04:35pm EDT(Seeking Alpha) 
Millipore Corp. Q2 2009 Earnings Call Transcript
Thursday, 6 Aug 2009 10:53pm EDT(Seeking Alpha) 
 
Name Current Position Compensation
Madaus, Martin Chairman of the Board, President, Chief Executive Officer 4,771,680
Wagner, Charles Chief Financial Officer, Vice President 1,344,510
Kershaw, Peter Vice President - Global Operations 1,192,270

Profile

Millipore Corporation (Millipore) is a life science company. The Company provides products and services that help its academic, biotechnology and pharmaceutical customers advance their research, development and production. Its products and services help customers increase their speed and improve... Full Description

Company Address

Millipore Corporation
290 Concord Road
Billerica   MA   01821
P: +1978.7154321
F: +1781.5333110

Analyst Research

Performance of Key Competitors

Company Price Change
Becton, Dickinson and Co. $75.25 +1.55
Bio-Rad Laboratories, Inc. $98.35 +0.82
Bio-Rad Laboratories, Inc. $97.83 -2.17
  MIL Industry
P/E(TTM) 22.76 12.80
P/S(TTM) 2.32 29.90
ROI(TTM) 6.84 2.35
ROE(TTM) 12.08 3.59
Consensus Recommendation Outperform
EPS Est. (Current Period) 1.12
EPS Est. (Current Year) 3.94
Total Revenue $411.86M
Net Income $40.20M
EPS $0.71